Purchase Order HHSN268201400033P

<p>The National Heart Lung and Blood Institute awarded a purchase order to Roche Diagnostics Corporation valued at $25,138.89 on December 24, 2013, with completion by August 1, 2014. Performance occurs at North Bethesda, Maryland. The order is firm fixed price for in vitro diagnostic equipment, reagents, or laboratory instruments supplied by the vendor to support the Institute's clinical and research operations.</p>

<p>The National Heart Lung and Blood Institute issued a purchase order to Roche Diagnostics Corporation valued at $40,000.00 on February 1, 2013, with ultimate completion on January 31, 2014.</p> <p>Performance takes place in Bethesda, Maryland. The order carries firm fixed-price pricing with no set-aside designation. Roche Diagnostics supplies in vitro diagnostic products, laboratory instruments, reagents, and associated medical technologies to federal healthcare agencies.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Roche Diagnostics Corporation valued at $33,333.33 on April 29, 2013, with completion by January 16, 2014. Performance takes place in Bethesda, Maryland. The order is firm fixed-price with no set-aside applied. The source does not specify the goods or services procured.</p>

<p>The National Heart Lung and Blood Institute issued a purchase order to Roche Diagnostics Corporation on January 19, 2012, for maintenance, repair, and rebuild of laboratory instruments and equipment, with a ceiling value of $45,000 and firm fixed-price terms. Place of performance is Bethesda, Maryland. The order is scheduled for ultimate completion on January 31, 2013. No set-aside category applied to this procurement.</p>

<p>The National Institutes of Health Clinical Center awarded a purchase order to Roche Diagnostics Corporation for $23,977.00 on May 17, 2013. Place of performance is Bethesda, Maryland. The order, which closed on December 31, 2013, covers diagnostic equipment, reagents, laboratory instruments, or associated medical products supplied under firm fixed-price terms. No set-aside applied.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for $9,240.00 on October 4, 2012, with ultimate completion on October 4, 2013. The order covers maintenance, repair, and rebuild of laboratory instruments and equipment on a firm fixed-price basis. Work is performed at Bethesda, Maryland.</p>

<p>The National Heart Lung and Blood Institute issued a purchase order to Life Technologies Corporation for $7,341.84 on December 9, 2013, with completion on December 9, 2014. The order covers a maintenance agreement, with place of performance in Bethesda, Maryland. Pricing is firm fixed price with no small business set-aside.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to O.n. Diagnostics, LLC for medical laboratory testing on October 1, 2012, with a ceiling value of $60,750.00. Work is performed in Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of September 30, 2013.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Applied Biosystems LLC for $12,923.46 on October 17, 2012, for a maintenance agreement with an ultimate completion date of October 19, 2013. The order carries firm fixed pricing with no set-aside. Place of performance is Bethesda, Maryland.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Roche Diagnostics Corporation valued at $18,788.00 on August 19, 2014. Work is performed in North Bethesda, Maryland. The order covers in vitro diagnostic equipment, reagents, or laboratory instruments under fixed-price terms with economic price adjustment. Ultimate completion is scheduled for September 18, 2014.</p>